Astura Medical, a high-growth, innovative spine technology company, today reported an annual revenue increase of 312% for the full year ending Dec. 31, 2017.

“Our market-leading growth rate in 2017 can be attributed to a number of factors, but it’s our rapidly increasing network of surgeon and distributor partners throughout the country that is the real validation on the quality of our technology and performance of our team,” said Joel Gambrell, President and CEO of Astura Medical.

2017 was highlighted by a number of other achievements for Astura, including the 510k approval and initial release of the BRIDALVEIL Occipital-Cervico-Thoracic (OCT) System, several key personnel hires, and significantly increasing inventory to support the rising demand for the company’s product portfolio.

“As we look ahead, we anticipate further growth to come from the continued success of our Phase One suite of products and our recent full commercial release of Bridalveil OCT,” stated Mr. Gambrell. “Our current momentum combined with the scheduled launch of our MIS Platform later this year, which will include an MIS Percutaneous Screw System and Expandable Posterior Lumbar Interbody Cages, positions us well for a strong performance in 2018.”